Warning letter
Global Vitality, Inc. dba Enzyme Process International: warning letter of Apr 16, 2020
FDA warning letter 585738 · Division of Human and Animal Food Operations West IV
Key facts
| Reference number | 585738 |
|---|---|
| Company | Global Vitality, Inc. dba Enzyme Process International |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Apr 16, 2020 |
| Posted date | May 5, 2020 |
| Issuing office | Division of Human and Animal Food Operations West IV |
| Product type | Food/Cosmetics |
| CFR sections cited | 201.5, 101, 101.4, 101.36, 111, 111.210, 111.255, 111.260, 101.9, 101.93(b), 101.9(b), 111.27(a) and 17 more |
| Inspection city | Chandler |
| Inspection ZIP | 85226 |
| Inspection start date | Apr 15, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: